Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Opioid-Related Disorders 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Barrett Esophagus 1 Advanced Cancers 1

Interventions

X-Rays 1 Vorinostat 1 Sorafenib 1 Magnetic Resonance Spectroscopy 1 Erlotinib Hydrochloride 1 Curcumin 1 Cetuximab 1 AH 111585 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Advanced Cancers × X-Rays × Clear all

NCT01432119 2013-04-09

Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡